Gastrointestinal Cancer Articles | Page 2

Immunotherapy Arrives in Gastric Cancer
Manish A. Shah, MD, discusses the advancements being made in the treatment of patients with advanced gastric and gastroesophageal junction cancer.
Expert Sheds Light on Recent Advances in mCRC
Shubham Pant, MD, shares his insight on the future direction of the treatment landscape of colorectal cancer.
Trastuzumab Deruxtecan Receives Expedited Review in Japan for Gastric Cancer
Japanese regulators have granted a Sakigake designation to trastuzumab deruxtecan (DS-8201), for the treatment of patients with HER2-positive gastric cancer that is refractory to trastuzumab (Herceptin).
FDA Grants Nivolumab/Ipilimumab Priority Review for MSI-H/dMMR Colorectal Cancer
The FDA has granted a priority review to a supplemental biologics license application for nivolumab plus ipilimumab for the treatment of adult patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer following progression on a fluoropyrimidine, oxaliplatin, and irinotecan.
 
Immunotherapy, Sidedness Strategies Enhancing mCRC Treatment
Chloe E. Atreya, MD, PhD, discusses the latest treatment advances in mCRC, including tumor sidedness and emerging immunotherapy strategies.
Lenvatinib Approved for HCC in Japan
Japan’s Pharmaceuticals and Medical Devices Agency has approved lenvatinib mesylate for the frontline treatment of patients with unresectable hepatocellular carcinoma.
 
Expert Highlights Precision Medicine Advances in GI Cancers
Eric A. Collisson, MD, discusses ongoing efforts to advance precision medicine in GI malignancies to improve the standard of care.
Novel Therapies Bring Hope in Biliary Tract Cancers
John Gordan, MD, PhD, discusses the challenges of treating patients with biliary tract cancers and novel therapies in development.
Atezolizumab, Cobimetinib Combo Active in mCRC
Atezolizumab in combination with cobimetinib induced a 31% disease control rate in patients with heavily-pretreated metastatic colorectal cancer.
Venook Highlights Impact of IDEA Trial in Colon Cancer
Alan P. Venook, MD, discusses the significance of the findings of the international IDEA study investigating doses of FOLFOX for patients with colon cancer.
Publication Bottom Border
Border Publication
x